TRADING UPDATES: Diurnal taps GBP20 million; Victoria buys new assets
TRADING UPDATES: Diurnal taps GBP20 million; Victoria buys new assets
Read moreTue, 28th May 2019 13:32
TRADING UPDATES: Diurnal taps GBP20 million; Victoria buys new assets
Read moreTRADING UPDATES: HSBC announces redemption of US dollar securities
Read moreTRADING UPDATES: Renew to buy J Browne; Idox in good start to year
Read more(Sharecast News) - Speciality pharmaceuticals company Diurnal reported 6% growth in first-half total revenue in its interim results on Tuesday, to £1.21m.
Read moreUPDATE: Diurnal Loss Widens In First Half; Signs Chronocort Deal
Read moreDiurnal Reports Widened Loss In First Half Despite Revenue Growth
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreDiurnal Inks Licence Agreement For Alkindi With Citrine Medicine
Read moreUK TRADING UPDATE SUMMARY: DWF Sets Up New Global Operating Structure
Read moreIN BRIEF: Diurnal Pleased With Alkindi Sales In First Half
Read moreIN BRIEF: Diurnal Inks Turkey Distribution Deal For Alkindi, Chronocort
Read moreIN BRIEF: Diurnal Submits Application To UK Regulators For Chronocort
Read moreIN BRIEF: Diurnal Inks European Patent For Chronocort
Read moreIN BRIEF: Diurnal Secures Grant Of European Patent For Alkindi
Read more(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced the grant of a patent for 'Alkindi', or hydrocortisone granules in capsules for opening, by the European Patent Office on Friday.
Read more